

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to lipoprotein particle (GO:0055094) | 8.84634305 |
| 2 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 7.62511873 |
| 3 | spindle assembly involved in mitosis (GO:0090307) | 7.07040829 |
| 4 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 5.95720506 |
| 5 | prostate gland growth (GO:0060736) | 5.88049107 |
| 6 | negative regulation of acute inflammatory response (GO:0002674) | 5.72779109 |
| 7 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 5.51657348 |
| 8 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 5.45799025 |
| 9 | gland morphogenesis (GO:0022612) | 5.22048439 |
| 10 | anterior/posterior axis specification, embryo (GO:0008595) | 5.03143121 |
| 11 | regulation of tight junction assembly (GO:2000810) | 4.97781457 |
| 12 | centrosome duplication (GO:0051298) | 4.80166650 |
| 13 | Golgi transport vesicle coating (GO:0048200) | 4.66113522 |
| 14 | COPI coating of Golgi vesicle (GO:0048205) | 4.66113522 |
| 15 | cell differentiation involved in embryonic placenta development (GO:0060706) | 4.62292403 |
| 16 | negative regulation of Rho protein signal transduction (GO:0035024) | 4.57330092 |
| 17 | inner cell mass cell proliferation (GO:0001833) | 4.53538147 |
| 18 | regulation of sequestering of triglyceride (GO:0010889) | 4.51357294 |
| 19 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.49496888 |
| 20 | regulation of energy homeostasis (GO:2000505) | 4.44899578 |
| 21 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 4.44016891 |
| 22 | negative regulation of lipid storage (GO:0010888) | 4.28834176 |
| 23 | white fat cell differentiation (GO:0050872) | 4.20448236 |
| 24 | cellular response to lithium ion (GO:0071285) | 4.16975907 |
| 25 | monocyte differentiation (GO:0030224) | 4.12728571 |
| 26 | mitochondrial fusion (GO:0008053) | 4.08217618 |
| 27 | lipoprotein transport (GO:0042953) | 4.00296190 |
| 28 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.99935989 |
| 29 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.97495165 |
| 30 | negative regulation of telomerase activity (GO:0051974) | 3.97104152 |
| 31 | response to caffeine (GO:0031000) | 3.83235596 |
| 32 | negative regulation of TOR signaling (GO:0032007) | 3.76826683 |
| 33 | myelination in peripheral nervous system (GO:0022011) | 3.72679557 |
| 34 | peripheral nervous system axon ensheathment (GO:0032292) | 3.72679557 |
| 35 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.68815929 |
| 36 | regulation of receptor biosynthetic process (GO:0010869) | 3.65617974 |
| 37 | mitochondrion morphogenesis (GO:0070584) | 3.65369828 |
| 38 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.63541115 |
| 39 | cell adhesion mediated by integrin (GO:0033627) | 3.42987629 |
| 40 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.42898897 |
| 41 | * positive regulation of nuclease activity (GO:0032075) | 3.41370021 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 3.37061608 |
| 43 | protein carboxylation (GO:0018214) | 3.32790810 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.32790810 |
| 45 | peroxisome fission (GO:0016559) | 3.32373844 |
| 46 | lymphangiogenesis (GO:0001946) | 3.29304495 |
| 47 | COPII vesicle coating (GO:0048208) | 3.27850784 |
| 48 | response to methylmercury (GO:0051597) | 3.27665806 |
| 49 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 3.21303150 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.20126251 |
| 51 | L-phenylalanine catabolic process (GO:0006559) | 3.20126251 |
| 52 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.15058732 |
| 53 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.15058732 |
| 54 | lysine metabolic process (GO:0006553) | 3.14501645 |
| 55 | lysine catabolic process (GO:0006554) | 3.14501645 |
| 56 | wound healing, spreading of epidermal cells (GO:0035313) | 3.12554169 |
| 57 | valine metabolic process (GO:0006573) | 3.11634536 |
| 58 | * ER-nucleus signaling pathway (GO:0006984) | 3.10586867 |
| 59 | * cellular response to unfolded protein (GO:0034620) | 3.10315269 |
| 60 | fatty acid transmembrane transport (GO:1902001) | 3.08831896 |
| 61 | macroautophagy (GO:0016236) | 3.08494516 |
| 62 | response to vitamin A (GO:0033189) | 3.08245690 |
| 63 | negative regulation of kidney development (GO:0090185) | 3.07884280 |
| 64 | phospholipid homeostasis (GO:0055091) | 3.06030278 |
| 65 | iron ion import (GO:0097286) | 3.05588150 |
| 66 | cellular response to arsenic-containing substance (GO:0071243) | 3.05480722 |
| 67 | * regulation of nuclease activity (GO:0032069) | 3.05112805 |
| 68 | complement activation, alternative pathway (GO:0006957) | 3.04973723 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.04698586 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04646017 |
| 71 | glycerol ether metabolic process (GO:0006662) | 3.02811431 |
| 72 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.01742144 |
| 73 | synapsis (GO:0007129) | 3.01461770 |
| 74 | carnitine shuttle (GO:0006853) | 3.00766299 |
| 75 | regulation of cholesterol homeostasis (GO:2000188) | 2.99997812 |
| 76 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.99454256 |
| 77 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.97736213 |
| 78 | germinal center formation (GO:0002467) | 2.97219945 |
| 79 | alpha-linolenic acid metabolic process (GO:0036109) | 2.96040284 |
| 80 | TOR signaling (GO:0031929) | 2.95636755 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.93399380 |
| 82 | L-phenylalanine metabolic process (GO:0006558) | 2.93399380 |
| 83 | positive regulation of glomerulus development (GO:0090193) | 2.92691979 |
| 84 | T cell lineage commitment (GO:0002360) | 2.91401623 |
| 85 | positive regulation of alcohol biosynthetic process (GO:1902932) | 2.90939028 |
| 86 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.89118106 |
| 87 | mannose metabolic process (GO:0006013) | 2.88121594 |
| 88 | 4-hydroxyproline metabolic process (GO:0019471) | 2.85408919 |
| 89 | embryonic camera-type eye development (GO:0031076) | 2.85209054 |
| 90 | regulation of receptor binding (GO:1900120) | 2.83323582 |
| 91 | regulation of telomerase activity (GO:0051972) | 2.83002084 |
| 92 | * cellular response to topologically incorrect protein (GO:0035967) | 2.82943783 |
| 93 | positive regulation of NIK/NF-kappaB signaling (GO:1901224) | 2.82810574 |
| 94 | lung-associated mesenchyme development (GO:0060484) | 2.80830530 |
| 95 | protein targeting to Golgi (GO:0000042) | 2.80069137 |
| 96 | sulfur amino acid catabolic process (GO:0000098) | 2.79482174 |
| 97 | artery development (GO:0060840) | 2.79436073 |
| 98 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.78248460 |
| 99 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.78182026 |
| 100 | apoptotic cell clearance (GO:0043277) | 2.77902574 |
| 101 | protein retention in ER lumen (GO:0006621) | 2.77769997 |
| 102 | protein kinase C signaling (GO:0070528) | 2.77379441 |
| 103 | tyrosine metabolic process (GO:0006570) | 2.76728587 |
| 104 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.76119501 |
| 105 | regulation of glial cell proliferation (GO:0060251) | 2.75487337 |
| 106 | ether metabolic process (GO:0018904) | 2.75299587 |
| 107 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.75018381 |
| 108 | regulation of alkaline phosphatase activity (GO:0010692) | 2.74495204 |
| 109 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.73831630 |
| 110 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.73515706 |
| 111 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.70003271 |
| 112 | NADH dehydrogenase complex assembly (GO:0010257) | 2.70003271 |
| 113 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.70003271 |
| 114 | regulation of protein activation cascade (GO:2000257) | 2.69812407 |
| 115 | aromatic amino acid family catabolic process (GO:0009074) | 2.68930128 |
| 116 | estrogen metabolic process (GO:0008210) | 2.68628866 |
| 117 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.68512738 |
| 118 | positive regulation of macroautophagy (GO:0016239) | 2.67624704 |
| 119 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.67531261 |
| 120 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.67489377 |
| 121 | glycine metabolic process (GO:0006544) | 2.67273195 |
| 122 | kynurenine metabolic process (GO:0070189) | 2.65913109 |
| 123 | vesicle coating (GO:0006901) | 2.65397154 |
| 124 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.65192090 |
| 125 | regulation of response to interferon-gamma (GO:0060330) | 2.64947861 |
| 126 | homocysteine metabolic process (GO:0050667) | 2.61836466 |
| 127 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.61421905 |
| 128 | definitive hemopoiesis (GO:0060216) | 2.60546590 |
| 129 | relaxation of cardiac muscle (GO:0055119) | 2.59958001 |
| 130 | mammary gland epithelial cell proliferation (GO:0033598) | 2.59407332 |
| 131 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59254237 |
| 132 | high-density lipoprotein particle remodeling (GO:0034375) | 2.59194951 |
| 133 | regulation of complement activation (GO:0030449) | 2.58814572 |
| 134 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.58110959 |
| 135 | establishment of protein localization to Golgi (GO:0072600) | 2.58038937 |
| 136 | cysteine metabolic process (GO:0006534) | 2.57441034 |
| 137 | * response to endoplasmic reticulum stress (GO:0034976) | 2.57408940 |
| 138 | positive regulation of p38MAPK cascade (GO:1900745) | 2.57078755 |
| 139 | interkinetic nuclear migration (GO:0022027) | 2.56654468 |
| 140 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.56018905 |
| 141 | detection of molecule of bacterial origin (GO:0032490) | 2.55680279 |
| 142 | regulation of fatty acid oxidation (GO:0046320) | 2.55666946 |
| 143 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.55563601 |
| 144 | exocrine pancreas development (GO:0031017) | 2.54950906 |
| 145 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.54303506 |
| 146 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.53757256 |
| 147 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.53485442 |
| 148 | regulation of triglyceride catabolic process (GO:0010896) | 2.53421961 |
| 149 | positive regulation of mitochondrial fission (GO:0090141) | 2.53119912 |
| 150 | negative regulation of complement activation (GO:0045916) | 2.53086720 |
| 151 | positive regulation of histone deacetylation (GO:0031065) | 2.52696348 |
| 152 | positive regulation of fatty acid oxidation (GO:0046321) | 2.52379582 |
| 153 | reverse cholesterol transport (GO:0043691) | 2.52228561 |
| 154 | urea cycle (GO:0000050) | 2.52048112 |
| 155 | urea metabolic process (GO:0019627) | 2.52048112 |
| 156 | heme biosynthetic process (GO:0006783) | 2.51537834 |
| 157 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.50695977 |
| 158 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.50695977 |
| 159 | ER overload response (GO:0006983) | 2.50528795 |
| 160 | cellular modified amino acid catabolic process (GO:0042219) | 2.49975594 |
| 161 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.49972106 |
| 162 | drug transmembrane transport (GO:0006855) | 2.49342657 |
| 163 | intestinal cholesterol absorption (GO:0030299) | 2.49152022 |
| 164 | negative regulation of fibrinolysis (GO:0051918) | 2.48879380 |
| 165 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.48772222 |
| 166 | blood vessel maturation (GO:0001955) | 2.47622725 |
| 167 | tryptophan metabolic process (GO:0006568) | 2.46894126 |
| 168 | positive regulation of glycolytic process (GO:0045821) | 2.46744962 |
| 169 | fatty acid beta-oxidation (GO:0006635) | 2.46283593 |
| 170 | tricarboxylic acid metabolic process (GO:0072350) | 2.45870971 |
| 171 | oxaloacetate metabolic process (GO:0006107) | 2.45780738 |
| 172 | plasma lipoprotein particle clearance (GO:0034381) | 2.45735499 |
| 173 | low-density lipoprotein particle clearance (GO:0034383) | 2.44399515 |
| 174 | carnitine transmembrane transport (GO:1902603) | 2.42406690 |
| 175 | hormone catabolic process (GO:0042447) | 2.42234489 |
| 176 | fatty acid oxidation (GO:0019395) | 2.40344641 |
| 177 | positive regulation of lipid catabolic process (GO:0050996) | 2.38423829 |
| 178 | bile acid biosynthetic process (GO:0006699) | 2.38146040 |
| 179 | regulation of ARF protein signal transduction (GO:0032012) | 2.38067911 |
| 180 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.37787488 |
| 181 | sequestering of metal ion (GO:0051238) | 2.37002662 |
| 182 | protein localization to endosome (GO:0036010) | 2.35886817 |
| 183 | lipid oxidation (GO:0034440) | 2.34711101 |
| 184 | intracellular lipid transport (GO:0032365) | 2.34339866 |
| 185 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.33928609 |
| 186 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.33138365 |
| 187 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.30665141 |
| 188 | regulation of cholesterol storage (GO:0010885) | 2.30438642 |
| 189 | * response to unfolded protein (GO:0006986) | 2.30011163 |
| 190 | short-chain fatty acid metabolic process (GO:0046459) | 2.29531013 |
| 191 | glutamate metabolic process (GO:0006536) | 2.28451511 |
| 192 | fatty acid homeostasis (GO:0055089) | 2.27971774 |
| 193 | triglyceride homeostasis (GO:0070328) | 2.27817114 |
| 194 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 11.9840923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 5.52825100 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.96215844 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.62770738 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.84760279 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.48323561 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.40803732 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.23233610 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.15197096 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.79998934 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.76201104 |
| 11 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69008158 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.47362207 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.46136751 |
| 14 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.33972084 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.32117570 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.28712227 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.24759478 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.20176084 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.07250360 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.02524635 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.97532314 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95722260 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.87912512 |
| 24 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.86475531 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76846121 |
| 26 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75076280 |
| 27 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.75029120 |
| 28 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.75029120 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74908192 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70742345 |
| 31 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.69556238 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69354763 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68374943 |
| 34 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.67398332 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65478575 |
| 36 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64311433 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.63791369 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63262586 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.61352282 |
| 40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57782477 |
| 41 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57593970 |
| 42 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56175557 |
| 43 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.55806989 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54853666 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51156287 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48180499 |
| 47 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.46988182 |
| 48 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.46988182 |
| 49 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44368696 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42642660 |
| 51 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.41755882 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41466139 |
| 53 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.40027663 |
| 54 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.39118243 |
| 55 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.38253517 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35213780 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34894683 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34894683 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34380960 |
| 60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33409195 |
| 61 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32626002 |
| 62 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28137273 |
| 63 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26699380 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26413604 |
| 65 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25868809 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25747841 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24976356 |
| 68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.24796577 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23409777 |
| 70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23342783 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.23241163 |
| 72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21697418 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20658385 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20580553 |
| 75 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20068471 |
| 76 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19056764 |
| 77 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16190351 |
| 78 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.15354930 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15012192 |
| 80 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14371221 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13970494 |
| 82 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13920566 |
| 83 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.13608118 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12831293 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12815892 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12246600 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11767899 |
| 88 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11613321 |
| 89 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11176632 |
| 90 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.10760213 |
| 91 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10414763 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10312269 |
| 93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10221474 |
| 94 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08601907 |
| 95 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08276630 |
| 96 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08248137 |
| 97 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08014175 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07473673 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06562893 |
| 100 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.06540040 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06352619 |
| 102 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05554710 |
| 103 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05538739 |
| 104 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04878168 |
| 105 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04099305 |
| 106 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04061736 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03997431 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03760937 |
| 109 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02943627 |
| 110 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02870896 |
| 111 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02625760 |
| 112 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02533086 |
| 113 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01379472 |
| 114 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01075863 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99798733 |
| 116 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99776111 |
| 117 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99655308 |
| 118 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99168667 |
| 119 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.99043531 |
| 120 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98750694 |
| 121 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98559297 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98422367 |
| 123 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98368586 |
| 124 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97890193 |
| 125 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97689407 |
| 126 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97331655 |
| 127 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97121514 |
| 128 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97000888 |
| 129 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96663324 |
| 130 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.96544016 |
| 131 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.96512824 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96230847 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95773083 |
| 134 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95214454 |
| 135 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93938646 |
| 136 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.93595531 |
| 137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93499914 |
| 138 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93146171 |
| 139 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92990456 |
| 140 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92560641 |
| 141 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91835291 |
| 142 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91772178 |
| 143 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91749436 |
| 144 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91607819 |
| 145 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.91272375 |
| 146 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90872581 |
| 147 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90296715 |
| 148 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90105551 |
| 149 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89280946 |
| 150 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88933870 |
| 151 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88840171 |
| 152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87623421 |
| 153 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.87234014 |
| 154 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87176921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.05845700 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.70737903 |
| 3 | MP0005367_renal/urinary_system_phenotyp | 3.96782340 |
| 4 | MP0000516_abnormal_urinary_system | 3.96782340 |
| 5 | MP0005365_abnormal_bile_salt | 3.49611123 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.38568598 |
| 7 | MP0001661_extended_life_span | 3.18327471 |
| 8 | MP0003300_gastrointestinal_ulcer | 3.16018992 |
| 9 | MP0003252_abnormal_bile_duct | 3.10173349 |
| 10 | MP0005360_urolithiasis | 2.97405407 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.85601921 |
| 12 | MP0001849_ear_inflammation | 2.67209704 |
| 13 | MP0003195_calcinosis | 2.52960157 |
| 14 | MP0003315_abnormal_perineum_morphology | 2.42722235 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.40850394 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.29432907 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25306730 |
| 18 | MP0009840_abnormal_foam_cell | 2.20286716 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.15617000 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.15035607 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.14656973 |
| 22 | MP0009053_abnormal_anal_canal | 2.13004170 |
| 23 | MP0010329_abnormal_lipoprotein_level | 2.11679266 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.08313753 |
| 25 | MP0003868_abnormal_feces_composition | 2.01388019 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.96138465 |
| 27 | MP0005083_abnormal_biliary_tract | 1.90261726 |
| 28 | MP0010678_abnormal_skin_adnexa | 1.89977014 |
| 29 | MP0001485_abnormal_pinna_reflex | 1.85149605 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.84097293 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.81250458 |
| 32 | MP0000015_abnormal_ear_pigmentation | 1.80598780 |
| 33 | MP0004130_abnormal_muscle_cell | 1.79801913 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.72181127 |
| 35 | MP0000383_abnormal_hair_follicle | 1.63495816 |
| 36 | MP0003045_fibrosis | 1.62165093 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.60174569 |
| 38 | MP0004510_myositis | 1.56995790 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.55816848 |
| 40 | * MP0000609_abnormal_liver_physiology | 1.53804951 |
| 41 | MP0004043_abnormal_pH_regulation | 1.51051902 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.50615271 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.49190414 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.48751212 |
| 45 | MP0002693_abnormal_pancreas_physiology | 1.46475966 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.43619447 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.43113739 |
| 48 | MP0005164_abnormal_response_to | 1.42163396 |
| 49 | MP0003303_peritoneal_inflammation | 1.40050862 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.38837956 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 1.38293902 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.37145083 |
| 53 | MP0005332_abnormal_amino_acid | 1.37132143 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 1.36294867 |
| 55 | MP0001944_abnormal_pancreas_morphology | 1.33887034 |
| 56 | MP0008057_abnormal_DNA_replication | 1.33037420 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.31645004 |
| 58 | MP0004036_abnormal_muscle_relaxation | 1.31270730 |
| 59 | MP0002282_abnormal_trachea_morphology | 1.29765606 |
| 60 | MP0005319_abnormal_enzyme/_coenzyme | 1.28074526 |
| 61 | MP0000003_abnormal_adipose_tissue | 1.27891101 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.27447365 |
| 63 | MP0008961_abnormal_basal_metabolism | 1.26099091 |
| 64 | MP0002928_abnormal_bile_duct | 1.21316159 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.20923019 |
| 66 | MP0000013_abnormal_adipose_tissue | 1.20789516 |
| 67 | MP0001835_abnormal_antigen_presentation | 1.20064861 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.17103840 |
| 69 | MP0001915_intracranial_hemorrhage | 1.16984347 |
| 70 | MP0005330_cardiomyopathy | 1.15572968 |
| 71 | MP0002653_abnormal_ependyma_morphology | 1.15351274 |
| 72 | MP0004087_abnormal_muscle_fiber | 1.15133636 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.12663353 |
| 74 | MP0002132_abnormal_respiratory_system | 1.09719458 |
| 75 | MP0002060_abnormal_skin_morphology | 1.08779798 |
| 76 | MP0005310_abnormal_salivary_gland | 1.08210255 |
| 77 | MP0005375_adipose_tissue_phenotype | 1.08151389 |
| 78 | MP0000604_amyloidosis | 1.06466639 |
| 79 | MP0003950_abnormal_plasma_membrane | 1.05327683 |
| 80 | MP0005174_abnormal_tail_pigmentation | 1.04640562 |
| 81 | MP0000749_muscle_degeneration | 1.04425988 |
| 82 | MP0002269_muscular_atrophy | 1.04321691 |
| 83 | MP0005666_abnormal_adipose_tissue | 1.03223470 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.02824363 |
| 85 | MP0005409_darkened_coat_color | 1.01011462 |
| 86 | MP0000747_muscle_weakness | 1.00775261 |
| 87 | MP0001697_abnormal_embryo_size | 1.00536915 |
| 88 | MP0005670_abnormal_white_adipose | 0.99602084 |
| 89 | MP0010630_abnormal_cardiac_muscle | 0.98395200 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.95897378 |
| 91 | MP0003075_altered_response_to | 0.95281240 |
| 92 | MP0001756_abnormal_urination | 0.95166483 |
| 93 | * MP0009765_abnormal_xenobiotic_induced | 0.94958955 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.93950356 |
| 95 | MP0009115_abnormal_fat_cell | 0.93431862 |
| 96 | MP0010368_abnormal_lymphatic_system | 0.93175990 |
| 97 | MP0002972_abnormal_cardiac_muscle | 0.92987167 |
| 98 | MP0000537_abnormal_urethra_morphology | 0.92365670 |
| 99 | MP0003690_abnormal_glial_cell | 0.91807727 |
| 100 | MP0000751_myopathy | 0.91797003 |
| 101 | MP0003436_decreased_susceptibility_to | 0.90997350 |
| 102 | MP0002168_other_aberrant_phenotype | 0.90447799 |
| 103 | MP0000613_abnormal_salivary_gland | 0.89192279 |
| 104 | MP0003936_abnormal_reproductive_system | 0.89060955 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.88133904 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87276384 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 0.86542611 |
| 108 | MP0005334_abnormal_fat_pad | 0.86143976 |
| 109 | MP0010352_gastrointestinal_tract_polyps | 0.85753873 |
| 110 | MP0000627_abnormal_mammary_gland | 0.85328659 |
| 111 | MP0002160_abnormal_reproductive_system | 0.83396695 |
| 112 | MP0002090_abnormal_vision | 0.83160463 |
| 113 | MP0000598_abnormal_liver_morphology | 0.82565876 |
| 114 | MP0006054_spinal_hemorrhage | 0.81777979 |
| 115 | MP0002419_abnormal_innate_immunity | 0.79136153 |
| 116 | MP0005275_abnormal_skin_tensile | 0.79115707 |
| 117 | MP0003937_abnormal_limbs/digits/tail_de | 0.78495148 |
| 118 | MP0003091_abnormal_cell_migration | 0.76493292 |
| 119 | MP0004808_abnormal_hematopoietic_stem | 0.76432303 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.74068518 |
| 121 | MP0004381_abnormal_hair_follicle | 0.73977080 |
| 122 | MP0001533_abnormal_skeleton_physiology | 0.73385151 |
| 123 | MP0004947_skin_inflammation | 0.73315085 |
| 124 | MP0003119_abnormal_digestive_system | 0.73164887 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.72937124 |
| 126 | MP0008469_abnormal_protein_level | 0.71739665 |
| 127 | MP0002971_abnormal_brown_adipose | 0.71315808 |
| 128 | MP0005620_abnormal_muscle_contractility | 0.70802472 |
| 129 | MP0002006_tumorigenesis | 0.70746445 |
| 130 | MP0003806_abnormal_nucleotide_metabolis | 0.69895163 |
| 131 | MP0005023_abnormal_wound_healing | 0.69865772 |
| 132 | MP0010386_abnormal_urinary_bladder | 0.69618020 |
| 133 | MP0000371_diluted_coat_color | 0.69165046 |
| 134 | MP0008775_abnormal_heart_ventricle | 0.69001361 |
| 135 | MP0003279_aneurysm | 0.67681296 |
| 136 | MP0002135_abnormal_kidney_morphology | 0.67396538 |
| 137 | MP0000767_abnormal_smooth_muscle | 0.67288495 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.67045240 |
| 139 | MP0005535_abnormal_body_temperature | 0.66910020 |
| 140 | MP0005397_hematopoietic_system_phenotyp | 0.66773503 |
| 141 | MP0001545_abnormal_hematopoietic_system | 0.66773503 |
| 142 | MP0005464_abnormal_platelet_physiology | 0.66644316 |
| 143 | MP0009642_abnormal_blood_homeostasis | 0.65306941 |
| 144 | MP0002396_abnormal_hematopoietic_system | 0.65093012 |
| 145 | MP0000049_abnormal_middle_ear | 0.64206143 |
| 146 | MP0001216_abnormal_epidermal_layer | 0.63070767 |
| 147 | MP0005408_hypopigmentation | 0.62258147 |
| 148 | MP0004782_abnormal_surfactant_physiolog | 0.60875963 |
| 149 | MP0001879_abnormal_lymphatic_vessel | 0.59371687 |
| 150 | MP0000377_abnormal_hair_follicle | 0.59099245 |
| 151 | MP0002998_abnormal_bone_remodeling | 0.57466171 |
| 152 | MP0004272_abnormal_basement_membrane | 0.56014668 |
| 153 | MP0000685_abnormal_immune_system | 0.53577489 |
| 154 | MP0002148_abnormal_hypersensitivity_rea | 0.52952957 |
| 155 | MP0003890_abnormal_embryonic-extraembry | 0.52554178 |
| 156 | MP0005000_abnormal_immune_tolerance | 0.52304231 |
| 157 | MP0000467_abnormal_esophagus_morphology | 0.50385874 |
| 158 | MP0005451_abnormal_body_composition | 0.47446868 |
| 159 | MP0002177_abnormal_outer_ear | 0.47370652 |
| 160 | MP0003283_abnormal_digestive_organ | 0.47186927 |
| 161 | MP0005389_reproductive_system_phenotype | 0.47077878 |
| 162 | MP0004134_abnormal_chest_morphology | 0.45968619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Short 1st metacarpal (HP:0010034) | 7.96787226 |
| 2 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 7.96787226 |
| 3 | Abnormality of the 1st metacarpal (HP:0010009) | 6.92308609 |
| 4 | Stenosis of the external auditory canal (HP:0000402) | 6.66532478 |
| 5 | Carpal bone hypoplasia (HP:0001498) | 5.53489569 |
| 6 | Ectopic kidney (HP:0000086) | 5.38581084 |
| 7 | Fused cervical vertebrae (HP:0002949) | 4.94949968 |
| 8 | Short phalanx of the thumb (HP:0009660) | 4.89702139 |
| 9 | Rectal fistula (HP:0100590) | 4.59151141 |
| 10 | Rectovaginal fistula (HP:0000143) | 4.59151141 |
| 11 | Hypoglycemic coma (HP:0001325) | 4.15965531 |
| 12 | Intestinal fistula (HP:0100819) | 4.08723579 |
| 13 | Vaginal fistula (HP:0004320) | 4.02809873 |
| 14 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.98264532 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.89646890 |
| 16 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.77420661 |
| 17 | Toxemia of pregnancy (HP:0100603) | 3.73577750 |
| 18 | Short hallux (HP:0010109) | 3.71388686 |
| 19 | Ketoacidosis (HP:0001993) | 3.71061288 |
| 20 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.55184499 |
| 21 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 3.53471079 |
| 22 | Deep venous thrombosis (HP:0002625) | 3.52071015 |
| 23 | Duplicated collecting system (HP:0000081) | 3.46827558 |
| 24 | Abnormality of the renal collecting system (HP:0004742) | 3.43470062 |
| 25 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.40866535 |
| 26 | Osteomalacia (HP:0002749) | 3.40553278 |
| 27 | Chromsome breakage (HP:0040012) | 3.40212928 |
| 28 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.38179102 |
| 29 | Absent thumb (HP:0009777) | 3.37799909 |
| 30 | Short humerus (HP:0005792) | 3.35591238 |
| 31 | Complement deficiency (HP:0004431) | 3.34288688 |
| 32 | Hypoglycemic seizures (HP:0002173) | 3.33304118 |
| 33 | Hyperglycemia (HP:0003074) | 3.28723218 |
| 34 | Xanthomatosis (HP:0000991) | 3.27300647 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.25984591 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.25469542 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23961205 |
| 38 | Oligomenorrhea (HP:0000876) | 3.22584018 |
| 39 | Abnormality of DNA repair (HP:0003254) | 3.21195356 |
| 40 | Decreased subcutaneous fat (HP:0001002) | 3.20554656 |
| 41 | Ketosis (HP:0001946) | 3.18943887 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 3.18710344 |
| 43 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 3.15398287 |
| 44 | Myocardial infarction (HP:0001658) | 3.13339481 |
| 45 | Abnormality of the nasal septum (HP:0000419) | 3.11511069 |
| 46 | Anal stenosis (HP:0002025) | 3.06142055 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.99385460 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.99385460 |
| 49 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.96256945 |
| 50 | Abnormality of the parathyroid morphology (HP:0011766) | 2.92708435 |
| 51 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.86638171 |
| 52 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.82178558 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.81820828 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.81820828 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.81820828 |
| 56 | Acanthocytosis (HP:0001927) | 2.80541163 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.76119938 |
| 58 | Hypoalphalipoproteinemia (HP:0003233) | 2.74189895 |
| 59 | Right ventricular cardiomyopathy (HP:0011663) | 2.73456328 |
| 60 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.72437496 |
| 61 | Skin nodule (HP:0200036) | 2.69400478 |
| 62 | Abnormality of complement system (HP:0005339) | 2.64293446 |
| 63 | Synostosis of carpal bones (HP:0005048) | 2.63378503 |
| 64 | Bundle branch block (HP:0011710) | 2.62564127 |
| 65 | Horseshoe kidney (HP:0000085) | 2.61285255 |
| 66 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.55524724 |
| 67 | Absent radius (HP:0003974) | 2.55128447 |
| 68 | Hyporeflexia of lower limbs (HP:0002600) | 2.54010958 |
| 69 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.50199093 |
| 70 | Symptomatic seizures (HP:0011145) | 2.46591354 |
| 71 | Mitral stenosis (HP:0001718) | 2.46010313 |
| 72 | Disproportionate short-trunk short stature (HP:0003521) | 2.43935907 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.43291516 |
| 74 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.42862013 |
| 75 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.41311436 |
| 76 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.41311436 |
| 77 | Congenital sensorineural hearing impairment (HP:0008527) | 2.40151933 |
| 78 | Epidermoid cyst (HP:0200040) | 2.38919054 |
| 79 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.38558918 |
| 80 | Hyperlipoproteinemia (HP:0010980) | 2.36183675 |
| 81 | Hyperuricemia (HP:0002149) | 2.34296717 |
| 82 | Increased purine levels (HP:0004368) | 2.34296717 |
| 83 | Absent forearm bone (HP:0003953) | 2.31435772 |
| 84 | Aplasia involving forearm bones (HP:0009822) | 2.31435772 |
| 85 | Prolonged partial thromboplastin time (HP:0003645) | 2.29905437 |
| 86 | Aneurysm (HP:0002617) | 2.27904176 |
| 87 | Joint hemorrhage (HP:0005261) | 2.23325357 |
| 88 | Abnormality of the carotid arteries (HP:0005344) | 2.22610420 |
| 89 | Atrioventricular block (HP:0001678) | 2.21767039 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 2.21632792 |
| 91 | Hyperammonemia (HP:0001987) | 2.19962506 |
| 92 | Polygenic inheritance (HP:0010982) | 2.18912658 |
| 93 | Albinism (HP:0001022) | 2.18704991 |
| 94 | Sudden death (HP:0001699) | 2.18208730 |
| 95 | Late onset (HP:0003584) | 2.18081718 |
| 96 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.16449332 |
| 97 | Hypolipoproteinemia (HP:0010981) | 2.15098109 |
| 98 | Cerebral aneurysm (HP:0004944) | 2.14016475 |
| 99 | Neoplasm of the oral cavity (HP:0100649) | 2.13767869 |
| 100 | Wide intermamillary distance (HP:0006610) | 2.13641265 |
| 101 | Hypoplasia of the odontoid process (HP:0003311) | 2.13494388 |
| 102 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.13450958 |
| 103 | Conjugated hyperbilirubinemia (HP:0002908) | 2.13139803 |
| 104 | Abnormality of the odontoid process (HP:0003310) | 2.08055501 |
| 105 | Glomerulonephritis (HP:0000099) | 2.07392340 |
| 106 | Retinal atrophy (HP:0001105) | 2.07066414 |
| 107 | Protuberant abdomen (HP:0001538) | 2.05794997 |
| 108 | Myoglobinuria (HP:0002913) | 2.05283453 |
| 109 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02958501 |
| 110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02958501 |
| 111 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02958501 |
| 112 | Fat malabsorption (HP:0002630) | 2.01696988 |
| 113 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.99685102 |
| 114 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.99298658 |
| 115 | Short thumb (HP:0009778) | 1.99296778 |
| 116 | Macroorchidism (HP:0000053) | 1.96265462 |
| 117 | Global brain atrophy (HP:0002283) | 1.96117802 |
| 118 | Exercise-induced myalgia (HP:0003738) | 1.96082706 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 1.93764426 |
| 120 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93759959 |
| 121 | Hematochezia (HP:0002573) | 1.93412606 |
| 122 | Hepatocellular carcinoma (HP:0001402) | 1.93280279 |
| 123 | Chorioretinal atrophy (HP:0000533) | 1.91984466 |
| 124 | Pathologic fracture (HP:0002756) | 1.91236589 |
| 125 | Abnormality of chromosome stability (HP:0003220) | 1.91185019 |
| 126 | Abnormal atrioventricular conduction (HP:0005150) | 1.91063444 |
| 127 | Curly hair (HP:0002212) | 1.90727673 |
| 128 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90078129 |
| 129 | Leukocytosis (HP:0001974) | 1.89070925 |
| 130 | Menstrual irregularities (HP:0000858) | 1.89070544 |
| 131 | Heart block (HP:0012722) | 1.87468595 |
| 132 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86490588 |
| 133 | Increased CSF protein (HP:0002922) | 1.85497550 |
| 134 | Abnormality of purine metabolism (HP:0004352) | 1.85170740 |
| 135 | Papilledema (HP:0001085) | 1.84690260 |
| 136 | Generalized aminoaciduria (HP:0002909) | 1.84294533 |
| 137 | Aortic aneurysm (HP:0004942) | 1.82779646 |
| 138 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.82109668 |
| 139 | Exercise-induced muscle cramps (HP:0003710) | 1.81661533 |
| 140 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.80368980 |
| 141 | Flared iliac wings (HP:0002869) | 1.80314852 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 1.80287601 |
| 143 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.80006405 |
| 144 | Cholelithiasis (HP:0001081) | 1.79582135 |
| 145 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.77795694 |
| 146 | Esophageal varix (HP:0002040) | 1.76321495 |
| 147 | Subacute progressive viral hepatitis (HP:0006572) | 1.75655871 |
| 148 | Long toe (HP:0010511) | 1.75459638 |
| 149 | Syncope (HP:0001279) | 1.74539844 |
| 150 | Insulin resistance (HP:0000855) | 1.74353282 |
| 151 | Hamartoma of the eye (HP:0010568) | 1.74126694 |
| 152 | Hydroxyprolinuria (HP:0003080) | 1.73712964 |
| 153 | Abnormality of proline metabolism (HP:0010907) | 1.73712964 |
| 154 | Tented upper lip vermilion (HP:0010804) | 1.73590220 |
| 155 | Nephritis (HP:0000123) | 1.72858983 |
| 156 | Increased connective tissue (HP:0009025) | 1.72374280 |
| 157 | Vitreoretinal degeneration (HP:0000655) | 1.72253819 |
| 158 | Axonal loss (HP:0003447) | 1.72070565 |
| 159 | Vertebral fusion (HP:0002948) | 1.71743456 |
| 160 | Abnormality of the musculature of the hand (HP:0001421) | 1.71639812 |
| 161 | Abnormality of the Achilles tendon (HP:0005109) | 1.70811599 |
| 162 | Onion bulb formation (HP:0003383) | 1.70198764 |
| 163 | Large for gestational age (HP:0001520) | 1.70149549 |
| 164 | Ureteral duplication (HP:0000073) | 1.69783223 |
| 165 | Vascular calcification (HP:0004934) | 1.69372949 |
| 166 | Neoplasm of the thyroid gland (HP:0100031) | 1.69257115 |
| 167 | Cardiovascular calcification (HP:0011915) | 1.68584829 |
| 168 | Hypobetalipoproteinemia (HP:0003563) | 1.68351260 |
| 169 | Dysmetric saccades (HP:0000641) | 1.67691410 |
| 170 | Bladder carcinoma (HP:0002862) | 1.67611285 |
| 171 | Bladder neoplasm (HP:0009725) | 1.67611285 |
| 172 | Hyperglycinuria (HP:0003108) | 1.66799580 |
| 173 | Difficulty climbing stairs (HP:0003551) | 1.66277375 |
| 174 | Abnormality of the preputium (HP:0100587) | 1.65061711 |
| 175 | Osteolytic defects of the hand bones (HP:0009699) | 1.63970420 |
| 176 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.63970420 |
| 177 | Distal upper limb amyotrophy (HP:0007149) | 1.63590762 |
| 178 | Upper limb amyotrophy (HP:0009129) | 1.63590762 |
| 179 | Stroke (HP:0001297) | 1.63006155 |
| 180 | Carpal synostosis (HP:0009702) | 1.62783108 |
| 181 | Hypoplastic ischia (HP:0003175) | 1.62193467 |
| 182 | Atrial fibrillation (HP:0005110) | 1.61823226 |
| 183 | Papillary thyroid carcinoma (HP:0002895) | 1.61406394 |
| 184 | Optic nerve coloboma (HP:0000588) | 1.59447588 |
| 185 | Submucous cleft hard palate (HP:0000176) | 1.59001898 |
| 186 | Renal agenesis (HP:0000104) | 1.57602751 |
| 187 | Paralysis (HP:0003470) | 1.56635521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.14514590 |
| 2 | CDK9 | 4.02864160 |
| 3 | ERN1 | 3.79830479 |
| 4 | INSRR | 3.41102178 |
| 5 | TRIB3 | 3.39940458 |
| 6 | PKN2 | 2.93951878 |
| 7 | EIF2AK3 | 2.92372657 |
| 8 | GRK1 | 2.66611087 |
| 9 | FRK | 2.65873696 |
| 10 | TRIM28 | 2.59278063 |
| 11 | TTN | 2.24939573 |
| 12 | SIK3 | 2.22268409 |
| 13 | SIK1 | 2.14333722 |
| 14 | RIPK1 | 2.10308044 |
| 15 | LATS1 | 2.05803041 |
| 16 | CLK1 | 2.05175193 |
| 17 | PLK2 | 1.84077892 |
| 18 | PTK6 | 1.82750307 |
| 19 | JAK1 | 1.82148740 |
| 20 | BCKDK | 1.80122558 |
| 21 | MAP3K2 | 1.74183819 |
| 22 | TAF1 | 1.71801122 |
| 23 | BLK | 1.70375361 |
| 24 | CAMK1D | 1.65813322 |
| 25 | EIF2AK1 | 1.60867368 |
| 26 | SCYL2 | 1.57971876 |
| 27 | FLT3 | 1.56334186 |
| 28 | ACVR1B | 1.53977773 |
| 29 | NLK | 1.47277354 |
| 30 | FGFR4 | 1.47209347 |
| 31 | DMPK | 1.46610532 |
| 32 | CAMK1G | 1.46544588 |
| 33 | EPHB1 | 1.40953586 |
| 34 | PDGFRA | 1.36995601 |
| 35 | STK3 | 1.36192740 |
| 36 | IRAK1 | 1.29471489 |
| 37 | TYK2 | 1.26433314 |
| 38 | STK39 | 1.23458029 |
| 39 | NEK9 | 1.22144180 |
| 40 | CDC7 | 1.17706412 |
| 41 | AKT3 | 1.17265776 |
| 42 | JAK2 | 1.16633394 |
| 43 | BMPR2 | 1.15486036 |
| 44 | SGK3 | 1.14279027 |
| 45 | BRSK2 | 1.09156680 |
| 46 | IRAK3 | 1.07900027 |
| 47 | RET | 1.07039897 |
| 48 | HIPK2 | 1.05360150 |
| 49 | FGFR3 | 1.01947537 |
| 50 | YES1 | 1.01854726 |
| 51 | PRKCH | 1.01748475 |
| 52 | MELK | 1.01292717 |
| 53 | TBK1 | 1.01048869 |
| 54 | EPHA3 | 1.00584331 |
| 55 | PBK | 0.99246527 |
| 56 | TGFBR2 | 0.96671789 |
| 57 | CAMKK1 | 0.96643093 |
| 58 | MST1R | 0.95195671 |
| 59 | BRD4 | 0.94681201 |
| 60 | MAP3K1 | 0.94186586 |
| 61 | LMTK2 | 0.92663039 |
| 62 | FER | 0.92005543 |
| 63 | PIK3CG | 0.91314207 |
| 64 | PRKD3 | 0.90203059 |
| 65 | MAP3K7 | 0.90029988 |
| 66 | MAP2K3 | 0.87588522 |
| 67 | MAP3K12 | 0.87454817 |
| 68 | STK10 | 0.86792684 |
| 69 | CSNK1A1L | 0.85817963 |
| 70 | KSR1 | 0.85662744 |
| 71 | MAP3K3 | 0.83322874 |
| 72 | BCR | 0.80800219 |
| 73 | CDK6 | 0.79579991 |
| 74 | PIK3CA | 0.77797023 |
| 75 | ERBB3 | 0.77190552 |
| 76 | KSR2 | 0.76724399 |
| 77 | MAP3K14 | 0.75333477 |
| 78 | PDK1 | 0.75112933 |
| 79 | PDPK1 | 0.74812677 |
| 80 | PDGFRB | 0.73427516 |
| 81 | TIE1 | 0.73254718 |
| 82 | MTOR | 0.71846645 |
| 83 | PDK2 | 0.71799429 |
| 84 | EEF2K | 0.71618601 |
| 85 | MAPK15 | 0.71524229 |
| 86 | SGK2 | 0.70540713 |
| 87 | RIPK4 | 0.70425156 |
| 88 | MAP3K10 | 0.70155453 |
| 89 | PTK2 | 0.69129291 |
| 90 | CDC42BPA | 0.68725636 |
| 91 | PRKAA1 | 0.67441230 |
| 92 | MAP3K5 | 0.67052138 |
| 93 | ADRBK2 | 0.66875174 |
| 94 | BMX | 0.66706106 |
| 95 | PRKD1 | 0.66531535 |
| 96 | LRRK2 | 0.66386082 |
| 97 | MET | 0.65931809 |
| 98 | CAMKK2 | 0.65592976 |
| 99 | TEC | 0.64851720 |
| 100 | PRKAA2 | 0.64756555 |
| 101 | DYRK3 | 0.64285397 |
| 102 | PRKD2 | 0.63922775 |
| 103 | CSNK1G1 | 0.63451360 |
| 104 | TAOK1 | 0.61971395 |
| 105 | CSF1R | 0.58458877 |
| 106 | WNK1 | 0.58310446 |
| 107 | MAPKAPK2 | 0.57398311 |
| 108 | PAK3 | 0.57009601 |
| 109 | GRK7 | 0.56971162 |
| 110 | SGK494 | 0.56965855 |
| 111 | SGK223 | 0.56965855 |
| 112 | JAK3 | 0.56747786 |
| 113 | LYN | 0.56366320 |
| 114 | SYK | 0.56076043 |
| 115 | RPS6KB1 | 0.54943617 |
| 116 | MAP2K4 | 0.54830816 |
| 117 | STK24 | 0.54680759 |
| 118 | BMPR1B | 0.54482935 |
| 119 | DAPK2 | 0.53523814 |
| 120 | ITK | 0.52801317 |
| 121 | ATR | 0.52015085 |
| 122 | CHUK | 0.50283694 |
| 123 | CSNK1G3 | 0.49882414 |
| 124 | OBSCN | 0.49341991 |
| 125 | MAP2K1 | 0.49147898 |
| 126 | HCK | 0.48653540 |
| 127 | PRKCE | 0.48349572 |
| 128 | CDK12 | 0.47078117 |
| 129 | MST4 | 0.46780690 |
| 130 | FES | 0.45974768 |
| 131 | TRPM7 | 0.45371569 |
| 132 | CSNK1G2 | 0.45305438 |
| 133 | CSK | 0.44901806 |
| 134 | ALK | 0.44672759 |
| 135 | SGK1 | 0.44568400 |
| 136 | STK38 | 0.44036029 |
| 137 | GSK3A | 0.43659985 |
| 138 | PTK2B | 0.43221319 |
| 139 | EGFR | 0.42998667 |
| 140 | ABL1 | 0.42574011 |
| 141 | NTRK1 | 0.42275746 |
| 142 | ATM | 0.42018970 |
| 143 | FGFR2 | 0.41260466 |
| 144 | NUAK1 | 0.41149195 |
| 145 | STK4 | 0.40446655 |
| 146 | MAP4K1 | 0.40119683 |
| 147 | DYRK1B | 0.39818345 |
| 148 | MAPK11 | 0.39256593 |
| 149 | KIT | 0.38465832 |
| 150 | MAP3K13 | 0.37684305 |
| 151 | ZAP70 | 0.35872725 |
| 152 | PRKACG | 0.34695521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.24027045 |
| 2 | Thyroid cancer_Homo sapiens_hsa05216 | 2.86384624 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78123787 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.68926961 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.27588587 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.20213431 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.08787571 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.04573473 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80657005 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.79378042 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.76356801 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75660232 |
| 13 | Protein export_Homo sapiens_hsa03060 | 1.74506150 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.66161139 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.63947594 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.58443670 |
| 17 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.53817166 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52736954 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48715797 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.47613817 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42516254 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40473246 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.40151658 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.39167053 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38324059 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36222191 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.35054107 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.33497639 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.32894123 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.32003888 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.31819765 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28041290 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.28017662 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26221703 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22928199 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16810698 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.16765760 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.16327169 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.15470258 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13528518 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13073556 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12128616 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03103956 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.02844293 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02731674 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98007440 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97874551 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97728676 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96971500 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95827047 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.95498679 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94723677 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93101368 |
| 54 | Melanoma_Homo sapiens_hsa05218 | 0.92646806 |
| 55 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.91972544 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88513655 |
| 57 | Measles_Homo sapiens_hsa05162 | 0.85612754 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85050863 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84879823 |
| 60 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83896970 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.83856293 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83590959 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83164905 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82915642 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82066567 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81897980 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81051548 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.80356391 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.79899763 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77801764 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76612348 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76310849 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.76238118 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74740539 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72989058 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71109241 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.70822091 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.70702161 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69486482 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.69145145 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68650274 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.67923081 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67239072 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.66975359 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66254115 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65546008 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65164142 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64183425 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63088228 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.62620039 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62435524 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.62426741 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62371282 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60882176 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60862371 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60782858 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60030471 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.60006847 |
| 99 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59711189 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59657036 |
| 101 | Focal adhesion_Homo sapiens_hsa04510 | 0.59152264 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59055070 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58874114 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57864432 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55732286 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.55276414 |
| 107 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53651949 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53518346 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52672047 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52589736 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51831177 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51756773 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51397185 |
| 114 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51319275 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50926544 |
| 116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50762550 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.50084424 |
| 118 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49671831 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48700872 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.44550031 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44039722 |
| 122 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43920646 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.43803735 |
| 124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43110234 |
| 125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42913281 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.42750858 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42588482 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42206054 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41592870 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40898257 |
| 131 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40280350 |
| 132 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40095196 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.39577801 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39536902 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39298529 |
| 136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38999985 |
| 137 | Renin secretion_Homo sapiens_hsa04924 | 0.38655846 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.38188142 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37821092 |
| 140 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37496977 |
| 141 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37156033 |
| 142 | Tuberculosis_Homo sapiens_hsa05152 | 0.37078571 |
| 143 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.36853578 |
| 144 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36814887 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.36478468 |
| 146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36302820 |
| 147 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35994337 |
| 148 | Platelet activation_Homo sapiens_hsa04611 | 0.35503568 |
| 149 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34705766 |
| 150 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34605958 |
| 151 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34309924 |
| 152 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34180916 |
| 153 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34082199 |
| 154 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33447760 |
| 155 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33304259 |

